Insider Transactions in Q1 2022 at Alphatec Holdings, Inc. (ATEC)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2022
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
SELL
Payment of exercise price or tax liability
|
Direct |
66,652
-4.29%
|
$666,520
$10.94 P/Share
|
|
Mar 18
2022
|
David Sponsel EVP, SALES |
SELL
Payment of exercise price or tax liability
|
Direct |
10,582
-1.61%
|
$105,820
$10.94 P/Share
|
|
Mar 18
2022
|
Brian Snider EVP, MARKETING |
SELL
Payment of exercise price or tax liability
|
Direct |
5,292
-0.79%
|
$52,920
$10.94 P/Share
|
|
Mar 18
2022
|
Kelli Mari Howell EVP, CLINICAL STRATEGIES |
SELL
Payment of exercise price or tax liability
|
Direct |
2,940
-0.54%
|
$29,400
$10.94 P/Share
|
|
Mar 18
2022
|
John Todd Koning CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,582
-3.45%
|
$105,820
$10.94 P/Share
|
|
Mar 11
2022
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,100
+22.77%
|
$11,000
$10.64 P/Share
|
|
Mar 08
2022
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,000
+20.0%
|
$22,000
$11.46 P/Share
|
|
Mar 08
2022
|
Jennifer N. Pritzker > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,000
+2.34%
|
$22,000
$11.42 P/Share
|
|
Mar 01
2022
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
5,100
-1.55%
|
$51,000
$10.94 P/Share
|
|
Feb 25
2022
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
8,000
-2.38%
|
$80,000
$10.26 P/Share
|
|
Feb 24
2022
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
12,500
-3.58%
|
$112,500
$9.44 P/Share
|
|
Feb 24
2022
|
Scott Lish CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
88,592
+11.98%
|
-
|
|
Feb 24
2022
|
Brian Snider EVP, MARKETING |
BUY
Grant, award, or other acquisition
|
Direct |
55,655
+4.07%
|
-
|
|
Feb 24
2022
|
Kelli Mari Howell EVP, CLINICAL STRATEGIES |
BUY
Grant, award, or other acquisition
|
Direct |
55,655
+4.96%
|
-
|
|
Feb 24
2022
|
John Todd Koning CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
110,161
+16.62%
|
-
|
|
Feb 24
2022
|
David Sponsel EVP, SALES |
BUY
Grant, award, or other acquisition
|
Direct |
115,385
+8.42%
|
-
|
|
Feb 24
2022
|
Craig E Hunsaker EVP, PEOPLE & CULTURE |
BUY
Grant, award, or other acquisition
|
Direct |
497,531
+13.72%
|
-
|
|
Feb 24
2022
|
Patrick Miles CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,085,874
+8.12%
|
-
|
|
Feb 22
2022
|
Scott Lish CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
4,760
-1.8%
|
$42,840
$9.66 P/Share
|